AVCR — Avricore Health Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro CapSucker Stock
- CA$17.94m
- CA$17.35m
- CA$1.77m
- 41
- 13
- 28
- 15
Annual income statement for Avricore Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.015 | 0.033 | 0.033 | 0.123 | 1.77 |
Cost of Revenue | |||||
Gross Profit | -0.001 | 0.015 | 0.017 | 0.031 | 0.457 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.48 | 1.95 | 1.05 | 1.79 | 2.59 |
Operating Profit | -3.46 | -1.91 | -1.02 | -1.67 | -0.818 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.46 | -1.92 | -1.17 | -1.71 | -0.818 |
Net Income After Taxes | -3.46 | -1.92 | -1.17 | -1.71 | -0.818 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.14 | -2.11 | -1.17 | -1.71 | -0.818 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.14 | -2.11 | -1.17 | -1.71 | -0.818 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.073 | -0.034 | -0.017 | -0.019 | -0.008 |